Role of soluble triggering receptor expressed in myeloid cells-1 in distinguishing SIRS, sepsis, and septic shock in the pediatric intensive care unit

被引:2
作者
Duramaz, Burcu Bursal [1 ]
Ankay, Nermin [2 ]
Yesilbas, Osman [3 ]
Kihtir, Hasan Serdar [4 ]
Yozgat, Can Yilmaz [5 ]
Petmezci, Mey Talip [6 ]
Gedikbasi, Asuman [7 ]
Sevketoglu, Esra [8 ]
机构
[1] Univ Hlth Sci, Kanuni Sultan Suleyman Training & Res Hosp, Dept Pediat Infect Dis, Istanbul, Turkey
[2] Near East Univ, Dept Pediat, Nicosia, Cyprus
[3] Karadeniz Tech Univ, Dept Pediat Intens Care Med, Trabzon, Turkey
[4] Antalya Training & Res Hosp, Dept Pediat Intens Care Med, Antalya, Turkey
[5] Bezmialem Vakif Univ, Fac Med, Adnan Menderes Bulvari, TR-34093 Istanbul, Turkey
[6] Okmeydani Training & Res Hosp, Dept Pediat Intens Care Med, Istanbul, Turkey
[7] Istanbul Univ, Istabul Med Fac, Inst Child Hlth Dept Pediat Basic Sci, Div Med Genet, Istanbul, Turkey
[8] Bakirkoy Sadi Konuk Training & Res Hosp, Dept Pediat Intens Care Med, Istanbul, Turkey
来源
ARCHIVES DE PEDIATRIE | 2021年 / 28卷 / 07期
关键词
Childhood; Pediatric intensive care unit; sTREM-1; MORTALITY; STREM-1; TREM;
D O I
10.1016/j.arcped.2021.06.001
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Research into new markers has been intensified for early diagnosis, prognosis, and differentiation of SIRS, sepsis, and septic shock in recent years. This study aimed to investigate the role of soluble triggering receptor expressed in myeloid cells-1 (sTREM-1) and interleukin (IL)-6 in distinguishing between systemic inflammatory response syndrome (SIRS), sepsis, and septic shock in pediatric intensive care unit (PICU) patients. Methods: Between June 2014 and July 2015, 90 consecutive patients who were treated in the PICU were included in this prospective observational study. Patients were divided into four groups: control (n = 23), SIRS (n = 22), sepsis (n = 23), and septic shock (n = 22). All patients were evaluated for white blood cell (WBC), serum C-reactive protein (CRP), procalcitonin (PCT), IL-6, and sTREM-1 levels at 0, 24, and 72 h of admission. The prognostic evaluations were made using the Pediatric Risk of Mortality III (PRISM III) and Pediatric Logistic Organ Dysfunction (PELOD) scores. Patients were evaluated in terms of age, gender, prognosis, pathogen growth in culture, PRISM III and PELOD score, WBC, CRP, PCT, IL-6, and sTREM-1 levels and a comparison was made between groups. Results: There was no significant difference between all groups in terms of the 0-, 24-, and 72-h sTREM-1 values (p = 0.761, p = 0.360, and p = 0.822, respectively). CRP and PCT values did not differ between the septic shock, sepsis, and SIRS groups at 0, 24, and 72 h. In the septic shock group, the 0-h IL-6 value was significantly higher than that of the SIRS group (p = 0.025). The 24-h IL-6 value in the septic shock group was significantly higher than the values of the sepsis and SIRS groups (p = 0.048 and p = 0.043, respectively). No significant difference was detected between the septic shock, sepsis, and SIRS groups in terms of IL-6 values at 72 h. Conclusion: sTREM-1 is not useful for the diagnosis of infection and for distinguishing between sepsis, septic shock, and SIRS since it does not offer a clear diagnostic value for PICU patients, unlike other reliable markers such as WBC, CRP, and PCT. Elevated IL-6 levels may indicate septic shock in PICU patients. More research on sTREM-1 is needed in this setting. (C) 2021 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 50 条
  • [21] Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease
    Shu, C-C
    Lee, L-N.
    Wu, M-F.
    Lee, C-H.
    Wang, J-T.
    Wang, J-Y.
    Yu, C-J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (10) : 1415 - 1420
  • [22] Diagnostic value of soluble triggering receptor expressed on myeloid cells in paediatric sepsis: a systematic review
    Pontrelli, Giuseppe
    De Crescenzo, Franco
    Buzzetti, Roberto
    Carducci, Francesca Calo
    Jenkner, Alessandro
    Amodio, Donato
    De Luca, Maia
    Chiurchiu, Sara
    Davies, Elin Haf
    Simonetti, Alessandra
    Ferretti, Elena
    Della Corte, Martina
    Gramatica, Luca
    Livadiotti, Susanna
    Rossi, Paolo
    ITALIAN JOURNAL OF PEDIATRICS, 2016, 42
  • [23] Serum Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-1 Associated with the Severity and Outcome of Acute Ischemic Stroke
    Huang, Jyun-Bin
    Chen, Nai-Ching
    Chen, Chien-Liang
    Fu, Mu-Hui
    Pan, Hsiu-Yung
    Hsu, Chung-Yao
    Chen, Shang-Der
    Chuang, Yao-Chung
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 13
  • [24] Roles of triggering receptor expressed on myeloid cells-1: More than just pneumonia
    Han, Jiajia
    Li, Li
    ADVANCES IN HUMAN BIOLOGY, 2024, 14 (01) : 18 - 24
  • [25] Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) as a Diagnostic Marker of Ventilator-Associated Pneumonia
    Palazzo, Steven J.
    Simpson, Terri A.
    Simmons, Jillian M.
    Schnapp, Lynn M.
    RESPIRATORY CARE, 2012, 57 (12) : 2052 - 2058
  • [26] Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis
    Molad, Yair
    Ofer-Shiber, Shachaf
    Pokroy-Shapira, Elisheva
    Oren, Shirly
    Shay-Aharoni, Hagit
    Babai, Ilan
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 (06) : 557 - 564
  • [27] Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Inflammatory Markers in Colorectal Cancer Surgery: A Prospective Cohort Study
    Derek, Lovorka
    Servis, Drazen
    Unic, Adriana
    CHINESE MEDICAL JOURNAL, 2017, 130 (22) : 2691 - 2696
  • [28] Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease
    Michalis Tzivras
    Vassilios Koussoulas
    Evangelos J Giamarellos-Bourboulis
    Dimitrios Tzivras
    Thomas Tsaganos
    Pantelis Koutoukas
    Helen Giamarellou
    Athanasios Archimandritis
    World Journal of Gastroenterology, 2006, (21) : 3416 - 3419
  • [29] Serum Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Procalcitonin Can Reflect Sepsis Severity and Predict Prognosis: A Prospective Cohort Study
    Li, Zhenyu
    Wang, Hongxia
    Liu, Jian
    Chen, Bing
    Li, Guangping
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [30] Diagnostic Performance of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Ventilator-Associated Pneumonia of Patients with Ischemic Stroke
    Yu, Yuetian
    Zhu, Cheng
    Liu, Chunyan
    Gao, Yuan
    Yin, Rong
    Cao, Jianguo
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2017, 2017